Further reading

Alexander, S. P. H., Mathie, A., and Peters, J. A. (2006) Guide to receptors and channels. British Journal of Pharmacology, 147 (Supplement 3) [PubMed: 16550176].

Bikker, J. A., Trumpp-Kallmeyer, S., and Humblet, C. (1998) G protein coupled receptors: models, mutagenesis, and drug design. Journal of Medicinal Chemistry, 41, 2911-2927 [DOI: 10.1021/jm970767a] [PubMed: 9685229].

Chalmers, D. T., and Behan, D. P. (2002) The use of constitutively active GPCRs in drug discovery and functional genomics. Nature Reviews Drug Discovery, 1, 599-608 [DOI: 10.1038/nrd872] [PubMed: 12402500].

Christopoulis, A. (2002) Allosteric binding sites on cell surface receptors: novel targets for drug discovery. Nature Reviews Drug Discovery, 1, 198-210 [DOI: 10.1038/nrd746].

Cohen, P. (2002) Protein kinases—the major drug targets of the twenty-first century? Nature Reviews Drug Discovery, 1, 309-315 [DOI: 10.1038/nrd773] [PubMed: 12120282].

Kenakin, T. (2002) Efficacy at G protein-coupled receptors. Nature Reviews Drug Discovery, 1, 103-110 [DOI: 10.1038/nrd722] [PubMed: 12120091].

Kobilka, B., and Schertler, G. F. X. (2008) New G protein-coupled receptor crystal structures: insights and limitations. Trends in Pharmacological Sciences, 29, 79-83 [DOI: 10.1016/j.tips.2007.11.009] [PubMed: 18194818].

Maehle, A-H., Prull, C-R., and Halliwell, R. F. (2002) The emergence of the drug receptor theory. Nature Reviews Drug Discovery, 1, 637-641 [DOI: 10.1038/nrd875] [PubMed: 12402503].

Tai, H. J., Grossmann, M., and Ji, I. (1998) G protein-coupled receptors. Journal of Biological Chemistry 273, 17299-17302 and 17979-17982 [DOI: 10.1074/jbc.273.31.19639].

Zhan-Guo, G., and Jacobson, K. A. (2006) Allosterism in membrane receptors. Drug Discovery Today, 11, 191-202 [DOI: 10.1016/S1359-6446(05)03689-5].